Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PADI4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | CDS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | KCTD19 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
mRNA | DNA2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | CHST11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | TNPO1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
mRNA | GPR143 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | RRAS | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | AMT | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |